Pathogenesis of marburg hemorrhagic fever in cynomolgus macaques

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Hensley, Lisa E ^a   Alves, Derron A ^a   Geisbert, Joan B ^b   Fritz, Elizabeth A ^b   Reed, Christopher ^a   Larsen, Tom ^a   Geisbert, Thomas W ^b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; FIBRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD EXAMINATION; BYSTANDER EFFECT; CELL LOSS; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DOWN REGULATION; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FIBRIN DEPOSITION; HISTOPATHOLOGY; KUPFFER CELL; LYMPH NODE CELL; LYMPHOCYTE; MACACA; MACROPHAGE; MARBURG HEMORRHAGIC FEVER; MARBURG VIRUS; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL; VIRUS CELL INTERACTION;

ANIMALS; DENDRITIC CELLS; IMMUNOHISTOCHEMISTRY; LIVER; LYMPHOID TISSUE; MACACA FASCICULARIS; MACROPHAGES; MARBURG VIRUS DISEASE; MONOCYTES;

EID: 80054745108     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir339     Document Type: Article

References (23)

1. Sanchez A, Geisbert TW, Feldmann H. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields virology, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2006: 1409-48.
2. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 10:63-77.
3. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 2006; 355:909-19. (Pubitemid 44315983)
4. Towner JS, Khristova ML, Sealy TK, et al. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 2006; 80:6497-516. (Pubitemid 43927452)
5. International Society for Infectious Diseases. Marburg hemorrhagic fever-The Netherlands ex Uganda. ProMED-mail (Archive Number 20080711.2115). http://www.promedmail.org. Accessed 8 October 2010.
6. Centers for Disease Control and Prevention. Imported case of Marburg hemorrhagic fever-Colorado, 2008. Morbid Mortal Wkly Rpt 2009; 58:1377-81.
7. Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 1998; 251:28-37. (Pubitemid 28527716)
8. Jones SM, Feldmann H, Stroher U, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 2005; 11:786-90. (Pubitemid 41021212)
9. Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, et al. Crossprotection against Marburg virus strains using a live, attenuated recombinant vaccine. J Virol 2006; 80:9659-66. (Pubitemid 44435640)
10. Swenson DL, Warfield KL, Larsen T, Alves DA, Coberley SS, Bavari S. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines 2008; 7:417-29. (Pubitemid 351656813)
11. Geisbert TW, Bailey M, Geisbert JB, et al. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburgvirus in nonhuman primates. J Virol 2010; 84:10386-94.
12. Simpson DIH, Zlotnik I, Rutter DA. Vervet monkey disease. Experimental infection of guinea pigs and monkeys with the causative agents. Br J Exp Pathol 1968; 49:458-64.
13. Simpson DIH. Marburg agent disease: in monkeys. Trans R Soc Trop Med Hyg 1969; 63:303-9.
14. Haas R, Maas G. Experimental infection of monkeys with the Marburg virus. In: Martini GA, Siegert R eds. Marburg virus disease. New York: Springer-Verlag, 1971: 136-43.
15. Murphy FA, Simpson DI, Whitfield SG, Zlotnik I, Carter GB. Marburg virus infection in monkeys. Ultrastructural studies. Lab Invest 1971; 24:279-91.
16. Lub MY, Sergeev AN, P'yankov OV, Petrishchenko VA, Kotlyarov LA. Some pathogenetic characteristics of disease in monkeys aerogenically infected with Marburg virus. Vopr Virusol 1995; 40:158-61. (Pubitemid 26101753)
17. Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, et al. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis 2007; 196(Suppl 2):S372-81. (Pubitemid 351417284)
18. Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS. Cellular immune response to Marburg virus infection in cynomolgus macaques. Viral Immunol 2008; 21:355-63.
19. Alves DA, Glynn AR, Steele KE, et al. Aerosol exposure to the Angola strain of Marburg virus causes lethal viral hemorrhagic fever in cynomolgus macaques. Vet Pathol 2010; 47:831-51.
20. Martini GA. Marburg virus disease. Clinical syndrome. In: Martini GA, Siegert R eds. Marburg virus disease. New York: Springer-Verlag, 1971: 1-9.
21. Siegert R, Shu HL, Slenczka W. Isolation and identification of the Marburg virus. Dtsch Med Wochenschr 1968; 93:604-12.
22. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/ macrophages is a key event. J Infect Dis 2003; 188:1618-29. (Pubitemid 38010671)
23. Hensley LE, Stevens EL, Yan SB, et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis 2007; 196(Suppl 2):S390-9.